Evidence map›Paper›PMID 27085324›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2017

Expressional profile of the diacylglycerol kinase eta gene DGKH.

Lena Weißflog, Nils Becker, Nelli Bossert, Florian Freudenberg, Sarah Kittel-Schneider, Andreas Reif

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Lena WeißflogDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Frankfurt, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt, Germany. lena.weissflog@kgu.de.
Nils BeckerDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Würzburg, Füchsleinstr. 15, 97080, Würzburg, Germany.
Nelli BossertDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Würzburg, Füchsleinstr. 15, 97080, Würzburg, Germany.
Florian FreudenbergDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Frankfurt, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt, Germany.
Sarah Kittel-SchneiderDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Frankfurt, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt, Germany.
Andreas ReifDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital of Frankfurt, Heinrich-Hoffmann-Str. 10, 60528, Frankfurt, Germany.
Goethe University Frankfurt · DEUniversity Hospital Frankfurt · DEUniversitätsklinikum Würzburg · DEUniversity of Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bipolar disorder (BPD) is a genetically complex mental disorder, which is characterized by recurrent depressive and manic episodes, occurring with a typical cyclical course. In a recent study, we were able to identify a risk haplotype for BPD, as well as for unipolar depression and adult attention-deficit/hyperactivity disorder (ADHD), within the DGKH gene. DGKH codes for the eta (η) isoform of diacylglycerol kinase, which is involved in the phosphoinositol pathway. In the present study, we determined the expressional profile of Dgkh using quantitative real-time PCR (qPCR), in situ hybridization and immunohistological staining in the human and in the mouse brain. Expression studies showed that two different Dgkh transcripts exhibited distinct occurrence in a variety of murine tissues and also differed in their expression levels. The proteins encoded by those transcripts differ in functional protein domains suggesting distinct biochemical and cell biological properties and functions. qPCR analyses revealed an increase in Dgkh expression during mouse brain development indicating a possible role of this kinase in late developmental stages. Immunostainings revealed strong Dgkh expression in neurons of the hippocampus and the cerebellum of the murine brain, whereas highest expression levels of DGKH in the human brain were found in the striatum. Taken together, our studies revealed expressional changes during mouse brain development and occurrence of Dgkη in neurons of regions that have been linked to BPD as well as ADHD in humans providing evidence for the implication of DGKH in those disorders.

Indexed as

AdultAgedAge FactorsAnimalsAnimals, NewbornBrainBrain Injuries, TraumaticDiacylglycerol KinaseDNA, RecombinantEmbryo, MammalianFemaleGene Expression Regulation, DevelopmentalGene Expression Regulation, EnzymologicGlial Fibrillary Acidic ProteinHumansMaleDGKH protein, humanDiacylglycerol KinaseDNA, RecombinantGlial Fibrillary Acidic ProteinRNA, MessengerTubulinBipolar disorderDiacylglycerol kinaseGene expressionGeneticsHistology

Identifiers

PMID27085324
OpenAlexW2341942531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.